Mathematical Modeling of BCG-based Bladder Cancer Treatment Using Socio-Demographics

• URL: http://arxiv.org/abs/2307.15084v1
• Date: Wed, 26 Jul 2023 05:54:06 GMT
• Title: Mathematical Modeling of BCG-based Bladder Cancer Treatment Using Socio-Demographics
• Authors: Elizaveta Savchenko, Ariel Rosenfeld, Svetlana Bunimovich-Mendrazitsky
• Abstract summary: Bladder cancer is one of the most prevalent types of cancer affecting all individuals alike. Current standard treatment for BC follows a routine weekly Bacillus Calmette-Guerin (BCG) immunotherapy-based therapy protocol.
• Score: 5.874094804342782
• License: http://creativecommons.org/licenses/by-nc-sa/4.0/
• Abstract: Cancer is one of the most widespread diseases around the world with millions of new patients each year. Bladder cancer is one of the most prevalent types of cancer affecting all individuals alike with no obvious prototypical patient. The current standard treatment for BC follows a routine weekly Bacillus Calmette-Guerin (BCG) immunotherapy-based therapy protocol which is applied to all patients alike. The clinical outcomes associated with BCG treatment vary significantly among patients due to the biological and clinical complexity of the interaction between the immune system, treatments, and cancer cells. In this study, we take advantage of the patient's socio-demographics to offer a personalized mathematical model that describes the clinical dynamics associated with BCG-based treatment. To this end, we adopt a well-established BCG treatment model and integrate a machine learning component to temporally adjust and reconfigure key parameters within the model thus promoting its personalization. Using real clinical data, we show that our personalized model favorably compares with the original one in predicting the number of cancer cells at the end of the treatment, with 14.8% improvement, on average.

Related papers

• An Explainable AI Model for Predicting the Recurrence of Differentiated Thyroid Cancer [0.0]
  This study employs machine learning, particularly deep learning models, to predict the recurrence of thyroid cancer. By analysing a dataset containing clinicopathological features of patients, the model achieved remarkable accuracy rates of 98% during training and 96% during testing.
  arXiv  Detail & Related papers  (2024-10-13T23:12:33Z)
• Multi-modal Medical Image Fusion For Non-Small Cell Lung Cancer Classification [7.002657345547741]
  Non-small cell lung cancer (NSCLC) is a predominant cause of cancer mortality worldwide. In this paper, we introduce an innovative integration of multi-modal data, synthesizing fused medical imaging (CT and PET scans) with clinical health records and genomic data. Our research surpasses existing approaches, as evidenced by a substantial enhancement in NSCLC detection and classification precision.
  arXiv  Detail & Related papers  (2024-09-27T12:59:29Z)
• From Glucose Patterns to Health Outcomes: A Generalizable Foundation Model for Continuous Glucose Monitor Data Analysis [50.80532910808962]
  We present GluFormer, a generative foundation model on biomedical temporal data based on a transformer architecture. GluFormer generalizes to 15 different external datasets, including 4936 individuals across 5 different geographical regions. It can also predict onset of future health outcomes even 4 years in advance.
  arXiv  Detail & Related papers  (2024-08-20T13:19:06Z)
• Benchmarking Histopathology Foundation Models for Ovarian Cancer Bevacizumab Treatment Response Prediction from Whole Slide Images [1.4999444543328293]
  We leverage the latest histopathology foundation models trained on large-scale whole slide image (WSI) to extract ovarian tumor tissue features for predicting bevacizumab response. Our survival models are able to stratify high- and low-risk cases with statistical significance.
  arXiv  Detail & Related papers  (2024-07-30T07:15:39Z)
• Improving Breast Cancer Grade Prediction with Multiparametric MRI Created Using Optimized Synthetic Correlated Diffusion Imaging [71.91773485443125]
  Grading plays a vital role in breast cancer treatment planning. The current tumor grading method involves extracting tissue from patients, leading to stress, discomfort, and high medical costs. This paper examines using optimized CDI$s$ to improve breast cancer grade prediction.
  arXiv  Detail & Related papers  (2024-05-13T15:48:26Z)
• Using Multiparametric MRI with Optimized Synthetic Correlated Diffusion Imaging to Enhance Breast Cancer Pathologic Complete Response Prediction [71.91773485443125]
  Neoadjuvant chemotherapy has recently gained popularity as a promising treatment strategy for breast cancer. The current process to recommend neoadjuvant chemotherapy relies on the subjective evaluation of medical experts. This research investigates the application of optimized CDI$s$ to enhance breast cancer pathologic complete response prediction.
  arXiv  Detail & Related papers  (2024-05-13T15:40:56Z)
• Survival Prediction Across Diverse Cancer Types Using Neural Networks [40.392772795903795]
  Gastric cancer and Colon adenocarcinoma represent widespread and challenging malignancies. Medical community has embraced the 5-year survival rate as a vital metric for estimating patient outcomes. This study introduces a pioneering approach to enhance survival prediction models for gastric and Colon adenocarcinoma patients.
  arXiv  Detail & Related papers  (2024-04-11T21:47:13Z)
• Cancer-Net BCa-S: Breast Cancer Grade Prediction using Volumetric Deep Radiomic Features from Synthetic Correlated Diffusion Imaging [82.74877848011798]
  The prevalence of breast cancer continues to grow, affecting about 300,000 females in the United States in 2023. The gold-standard Scarff-Bloom-Richardson (SBR) grade has been shown to consistently indicate a patient's response to chemotherapy. In this paper, we study the efficacy of deep learning for breast cancer grading based on synthetic correlated diffusion (CDI$s$) imaging.
  arXiv  Detail & Related papers  (2023-04-12T15:08:34Z)
• Enhancing Clinical Support for Breast Cancer with Deep Learning Models using Synthetic Correlated Diffusion Imaging [66.63200823918429]
  We investigate enhancing clinical support for breast cancer with deep learning models. We leverage a volumetric convolutional neural network to learn deep radiomic features from a pre-treatment cohort. We find that the proposed approach can achieve better performance for both grade and post-treatment response prediction.
  arXiv  Detail & Related papers  (2022-11-10T03:02:12Z)
• Multi-Scale Hybrid Vision Transformer for Learning Gastric Histology: AI-Based Decision Support System for Gastric Cancer Treatment [50.89811515036067]
  Gastric endoscopic screening is an effective way to decide appropriate gastric cancer (GC) treatment at an early stage, reducing GC-associated mortality rate. We propose a practical AI system that enables five subclassifications of GC pathology, which can be directly matched to general GC treatment guidance.
  arXiv  Detail & Related papers  (2022-02-17T08:33:52Z)
• Leveraging a Joint of Phenotypic and Genetic Features on Cancer Patient Subgrouping [7.381190270069632]
  We developed a system leveraging a joint of phenotypic and genetic features for cancer patient subgrouping. In feature preprocessing, we performed filtering, retaining the most relevant features. In cancer patient classification, we utilized nine different machine learning models, Random Forests (RF), Decision Tree (DT), Support Vector Machine (SVM), Naive Bayes (NB), Logistic Regression (LR), Multilayer Perceptron (MLP), Gradient Boosting (GB), Convolutional Neural Network (CNN), and Feedforward Neural Network (FNN)
  arXiv  Detail & Related papers  (2021-03-30T13:07:05Z)
• Personalized pathology test for Cardio-vascular disease: Approximate Bayesian computation with discriminative summary statistics learning [48.7576911714538]
  We propose a platelet deposition model and an inferential scheme to estimate the biologically meaningful parameters using approximate computation. This work opens up an unprecedented opportunity of personalized pathology test for CVD detection and medical treatment.
  arXiv  Detail & Related papers  (2020-10-13T15:20:21Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.